Development
Cresco Labs Inc.
CL
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -8.35% | -8.93% | -7.31% | -4.13% | 2.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.35% | -8.93% | -7.31% | -4.13% | 2.39% |
| Cost of Revenue | -5.76% | 0.87% | 7.75% | 8.12% | 12.30% |
| Gross Profit | -11.00% | -18.10% | -20.40% | -14.61% | -6.11% |
| SG&A Expenses | -16.14% | -3.66% | 0.79% | 5.16% | 12.51% |
| Depreciation & Amortization | 18.91% | 7.70% | -6.96% | -0.77% | -4.48% |
| Other Operating Expenses | -16.47% | 10.96% | 10.96% | -13.27% | -13.27% |
| Total Operating Expenses | -9.54% | -0.54% | 4.58% | 6.06% | 11.10% |
| Operating Income | 6.99% | -67.48% | -76.61% | -64.77% | -49.06% |
| Income Before Tax | -15.76% | -861.49% | 27.17% | 44.96% | 50.57% |
| Income Tax Expenses | -62.95% | -45.03% | 27.23% | 75.02% | 121.75% |
| Earnings from Continuing Operations | 16.67% | -675.16% | 16.98% | 25.78% | 27.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 14.07% | 241.17% | 213.03% | 143.69% | 116.68% |
| Net Income | 17.22% | -418.77% | 28.38% | 33.65% | 33.65% |
| EBIT | 6.99% | -67.48% | -76.61% | -64.77% | -49.06% |
| EBITDA | 13.23% | -39.78% | -49.78% | -40.50% | -28.30% |
| EPS Basic | 23.89% | -380.61% | 35.45% | 40.04% | 40.88% |
| Normalized Basic EPS | 3.70% | 1.50% | -98.51% | -94.54% | -83.80% |
| EPS Diluted | 23.89% | -380.61% | 35.56% | 40.21% | 41.05% |
| Normalized Diluted EPS | 3.70% | 1.50% | -98.51% | -94.54% | -83.80% |
| Average Basic Shares Outstanding | 8.58% | 7.50% | 7.13% | 9.08% | 13.66% |
| Average Diluted Shares Outstanding | 8.58% | 7.50% | 7.13% | 9.08% | 13.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |